Daridorexant, a new dual orexin receptor antagonist, in elderly subjects with insomnia disorder
Gary Zammit(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dieter Kunz(Charité - Universitätsmedizin Berlin), D. Sebök Kinter(Inserm), Scott Pain(Idorsia (Switzerland)), Yosef T. Mansour(Inserm), Yves Dauvilliers(Inserm)
Cited by 103
Related Papers
National Sleep Foundation's sleep quality recommendations: first report
|Sleep Health|2016|1.3k
Short Sleep Duration as a Risk Factor for Hypertension
|Hypertension|2006|1.2k
Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study
|Brain|2019|1.1k
Narcolepsy with cataplexy
|The Lancet|2007|716
Narcolepsy — clinical spectrum, aetiopathophysiology, diagnosis and treatment
|Nature Reviews Neurology|2019|634